TY  - GEN
AU  - Fiolet, Aernoud T L
AU  - Poorthuis, Michiel H F
AU  - Opstal, Tjerk S J
AU  - Amarenco, Pierre
AU  - Boczar, Kevin Emery
AU  - Buysschaert, Ian
AU  - Budgeon, Charley
AU  - Chan, Noel C
AU  - Cornel, Jan H
AU  - Jolly, Sanjit S
AU  - Layland, Jamie
AU  - Lemmens, Robin
AU  - Mewton, Nathan
AU  - Nidorf, Stefan M
AU  - Pascual-Figal, Domingo A
AU  - Price, Christopher
AU  - Shah, Binita
AU  - Tardif, Jean-Claude
AU  - Thompson, Peter L
AU  - Tijssen, Jan G P
AU  - Tsivgoulis, Georgios
AU  - Walsh, Cathal
AU  - Wang, Yongjun
AU  - Weimar, Christian
AU  - Eikelboom, John W
AU  - Mosterd, Arend
AU  - Kelly, Peter J
PY  - 2024
UR  - https://hdl.handle.net/20.500.12105/25902
AB  - Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes. In this trial-level...
AB  - There was no funding source for this study.
LA  - eng
KW  - Colchicine
KW  - MACE
KW  - Meta-analysis
KW  - Safety
KW  - Stroke
TI  - Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials.
TY  - research article
ER  -